Colonoscopic surveillance in inflammatory bowel disease

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Purpose of review: To describe recent findings in the literature aimed at decreasing systematic error in dysplasia surveillance in inflammatory bowel disease. Recent findings: Despite great promise, colonoscopic surveillance in inflammatory bowel disease has yet to be demonstrated to reduce colorectal cancer mortality. In part, this stems from a number of inherent systematic troubles, including low rates of observer agreement among pathologists; lack of consensus on the natural history of dysplasia, particularly low-grade dysplasia; the patchy nature of dysplasia, which leads to sampling error caused by insufficient biopsy by endoscopists; and incomplete patient follow-up. Recent publications that have focused on defining better the natural history of different levels of dysplasia and improving dysplasia identification at the time of colonoscopy may aid in overcoming the flaws of surveillance. The key recent findings include conflicting evidence on the relative danger of flat low-grade dysplasia, the safety of treating polypoid low-grade dysplasia as a benign adenoma in the absence of flat dysplasia in the rest of the colon or the surrounding mucosa, and preliminary support of chromoendoscopy to target dysplasia better during colonoscopy and to limit unnecessary nontargeted biopsies. Summary: These and other advances stand a reasonable chance of making surveillance a more accurate tool to discriminate between patients with chronic colitis likely to progress to advanced pathology and those less likely to do so. Such advances may result in effective surveillance in which both colorectal cancer mortality and unnecessary colectomy may be limited.

Original languageEnglish (US)
Pages (from-to)585-588
Number of pages4
JournalCurrent Opinion in Gastroenterology
Volume21
Issue number5
DOIs
StatePublished - Sep 1 2005
Externally publishedYes

Fingerprint

Colonoscopy
Natural History
Inflammatory Bowel Diseases
Colorectal Neoplasms
Biopsy
Mortality
Colectomy
Selection Bias
Colitis
Adenoma
Colon
Mucous Membrane
Pathology
Safety
Pathologists

Keywords

  • Chromoendoscopy
  • Colorectal cancer
  • Flat low-grade dysplasia
  • Polypoid low-grade dysplasia

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Colonoscopic surveillance in inflammatory bowel disease. / Ullman, Thomas A.

In: Current Opinion in Gastroenterology, Vol. 21, No. 5, 01.09.2005, p. 585-588.

Research output: Contribution to journalReview article

@article{70f411d76e0543fca3835941961b6512,
title = "Colonoscopic surveillance in inflammatory bowel disease",
abstract = "Purpose of review: To describe recent findings in the literature aimed at decreasing systematic error in dysplasia surveillance in inflammatory bowel disease. Recent findings: Despite great promise, colonoscopic surveillance in inflammatory bowel disease has yet to be demonstrated to reduce colorectal cancer mortality. In part, this stems from a number of inherent systematic troubles, including low rates of observer agreement among pathologists; lack of consensus on the natural history of dysplasia, particularly low-grade dysplasia; the patchy nature of dysplasia, which leads to sampling error caused by insufficient biopsy by endoscopists; and incomplete patient follow-up. Recent publications that have focused on defining better the natural history of different levels of dysplasia and improving dysplasia identification at the time of colonoscopy may aid in overcoming the flaws of surveillance. The key recent findings include conflicting evidence on the relative danger of flat low-grade dysplasia, the safety of treating polypoid low-grade dysplasia as a benign adenoma in the absence of flat dysplasia in the rest of the colon or the surrounding mucosa, and preliminary support of chromoendoscopy to target dysplasia better during colonoscopy and to limit unnecessary nontargeted biopsies. Summary: These and other advances stand a reasonable chance of making surveillance a more accurate tool to discriminate between patients with chronic colitis likely to progress to advanced pathology and those less likely to do so. Such advances may result in effective surveillance in which both colorectal cancer mortality and unnecessary colectomy may be limited.",
keywords = "Chromoendoscopy, Colorectal cancer, Flat low-grade dysplasia, Polypoid low-grade dysplasia",
author = "Ullman, {Thomas A.}",
year = "2005",
month = "9",
day = "1",
doi = "10.1097/01.mog.0000174219.07957.36",
language = "English (US)",
volume = "21",
pages = "585--588",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Colonoscopic surveillance in inflammatory bowel disease

AU - Ullman, Thomas A.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Purpose of review: To describe recent findings in the literature aimed at decreasing systematic error in dysplasia surveillance in inflammatory bowel disease. Recent findings: Despite great promise, colonoscopic surveillance in inflammatory bowel disease has yet to be demonstrated to reduce colorectal cancer mortality. In part, this stems from a number of inherent systematic troubles, including low rates of observer agreement among pathologists; lack of consensus on the natural history of dysplasia, particularly low-grade dysplasia; the patchy nature of dysplasia, which leads to sampling error caused by insufficient biopsy by endoscopists; and incomplete patient follow-up. Recent publications that have focused on defining better the natural history of different levels of dysplasia and improving dysplasia identification at the time of colonoscopy may aid in overcoming the flaws of surveillance. The key recent findings include conflicting evidence on the relative danger of flat low-grade dysplasia, the safety of treating polypoid low-grade dysplasia as a benign adenoma in the absence of flat dysplasia in the rest of the colon or the surrounding mucosa, and preliminary support of chromoendoscopy to target dysplasia better during colonoscopy and to limit unnecessary nontargeted biopsies. Summary: These and other advances stand a reasonable chance of making surveillance a more accurate tool to discriminate between patients with chronic colitis likely to progress to advanced pathology and those less likely to do so. Such advances may result in effective surveillance in which both colorectal cancer mortality and unnecessary colectomy may be limited.

AB - Purpose of review: To describe recent findings in the literature aimed at decreasing systematic error in dysplasia surveillance in inflammatory bowel disease. Recent findings: Despite great promise, colonoscopic surveillance in inflammatory bowel disease has yet to be demonstrated to reduce colorectal cancer mortality. In part, this stems from a number of inherent systematic troubles, including low rates of observer agreement among pathologists; lack of consensus on the natural history of dysplasia, particularly low-grade dysplasia; the patchy nature of dysplasia, which leads to sampling error caused by insufficient biopsy by endoscopists; and incomplete patient follow-up. Recent publications that have focused on defining better the natural history of different levels of dysplasia and improving dysplasia identification at the time of colonoscopy may aid in overcoming the flaws of surveillance. The key recent findings include conflicting evidence on the relative danger of flat low-grade dysplasia, the safety of treating polypoid low-grade dysplasia as a benign adenoma in the absence of flat dysplasia in the rest of the colon or the surrounding mucosa, and preliminary support of chromoendoscopy to target dysplasia better during colonoscopy and to limit unnecessary nontargeted biopsies. Summary: These and other advances stand a reasonable chance of making surveillance a more accurate tool to discriminate between patients with chronic colitis likely to progress to advanced pathology and those less likely to do so. Such advances may result in effective surveillance in which both colorectal cancer mortality and unnecessary colectomy may be limited.

KW - Chromoendoscopy

KW - Colorectal cancer

KW - Flat low-grade dysplasia

KW - Polypoid low-grade dysplasia

UR - http://www.scopus.com/inward/record.url?scp=23944459062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944459062&partnerID=8YFLogxK

U2 - 10.1097/01.mog.0000174219.07957.36

DO - 10.1097/01.mog.0000174219.07957.36

M3 - Review article

C2 - 16093774

AN - SCOPUS:23944459062

VL - 21

SP - 585

EP - 588

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 5

ER -